Posters highlight Remote Therapeutic Monitoring (RTM) implementation insights and outcomes from more than 2.2 million patient-reported observations
WASHINGTON, July 1, 2025 /PRNewswire/ — Adhere+, a telehealth company focused on improving patient outcomes through a SaaS-based telehealth care plan adherence and medication compliance technology platform, today announced that two abstracts have been accepted for presentation at the American Society of Pain & Neuroscience (ASPN) Annual Conference, taking place July 17–20, 2025, in Miami.
The two posters will present new research on RTM implementation frameworks and real-world adherence patterns across chronic pain, migraine, and musculoskeletal conditions. Both studies draw on Adhere+’s extensive national dataset of more than 2.2 million patient-reported outcomes, offering valuable insight into digital adherence strategies and interdisciplinary care.
“We’re pleased to share this work with the pain and neuroscience community at ASPN 2025,” said Jim Breidenstein, CEO of Adhere+. “These presentations represent not just data, but the real-world impact of digital tools that help providers stay connected to patients and improve outcomes between visits.”
Event Details
American Society of Pain & Neuroscience (ASPN) Annual Conference
https://aspnpain.com/miami2025/
July 17–20, 2025 Miami, Florida
Presentation Details
Title: Remote Therapeutic Monitoring (RTM): Key Criteria for Evaluation and Implementation
Authors: Lynn Webster, MD; Scott Cashon; Jeff Huynh; Dan Cohen
Date/Time: Friday, July 18 (10:25-10:45 am; 1:50-2:20 pm)
Saturday, July 19 (9:40-10:00 am; 2:25-2:55 pm)
Title: Multi-Specialty RTM Outcomes: A Preview of 2.2M+ ePROs from a National
Observational Cohort
Authors: Lynn Webster, MD; Scott Cashon; Jeff Huynh; Dan Cohen
Date/Time: Friday, July 18 (10:25-10:45 am; 1:50-2:20 pm)
Saturday, July 19 (9:40-10:00 am; 2:25-2:55 pm)
About Adhere+
Adhere+ is a medical treatment compliance platform, focused on creating a personalized pathway to support chronic care interventions for patients suffering from chronic care treatment conditions including pain, opioid/substance use disorders (SUD) and obesity. The SaaS platform is technology based, clinically validated via ten (10) published and peer-reviewed clinical trials. The Adhere+ approach is a user-friendly, digital platform to provide the physician with daily, evidence-based telehealth ePros interventions to improve patient compliance with treatment protocols, leading to better health outcomes, and a reduction in related healthcare costs. The program aligns with several AMA CPT payment codes for a potential reimbursable benefit.
Contact
Investors:
Tiberend Strategic Advisors, Inc.
Jon Nugent
205-566-3026
jnugent@tiberend.com
Media:
Tiberend Strategic Advisors, Inc.
Eric Reiss
ereiss@tiberend.com
Adhere+:
Dan Cohen, President and Co-Founder
202-329-1825
dlc@adhereplus.com
SOURCE Adhere+
Health Journey Addresses 'Best GLP-1 Supplement' Question with Akkermansia-Based Formula Analysis as Six-Month Costs Compare…
A Revolutionary ATCA/VME/VXI 3D-Flow Board: 512 Channels, >2,800 Programmable Operations—Scalable to >50,000 Operations on Each…
After President Trump's Marijuana Executive Order, Will the DEA Act-or Be Compelled by the Courts?"Despite…
Boards and executive buyers are raising the 2026 bar for all product and service rankings…
Boards and executive buyers are raising the 2026 bar for all product and service rankings…
Tampa based Celebrity Board-Certified Plastic Surgeon Dr. Meegan Gruber expands an interactive approach that allows…